Trial of the novel peroral anti-tumor treatment in patients with solid tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511215-21-00

Acronym

TU31-KH1

Enrollment

Registered

2024-09-09

Start date

2022-06-07

Completion date

Unknown

Last updated

2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast, colon, esophagus, head and neck, Metastatic or locally advanced solid tumors for which no standard therapy exists or standard therapy has failed: tumors of lung, ovary and/or fallopian tube or primary peritoneal high-grade serous carcinoma, stomach

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Czechia

Outcome results